相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape
Samik Upadhaya et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma
Hussein A. Tawbi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
CDK4 and CDK6 kinases: From basic science to cancer therapy
Anne Fassl et al.
SCIENCE (2022)
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma
Xisha Chen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma
Jing Zhang et al.
BIOMARKER RESEARCH (2022)
Hyperprogressive Disease in Malignant Carcinoma With Immune Checkpoint Inhibitor Use: A Review
Xiaojun Liu et al.
FRONTIERS IN NUTRITION (2022)
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Eμ-TCL1 mice
Bola S. Hanna et al.
HAEMATOLOGICA (2021)
Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells
Marianne Strazza et al.
COMMUNICATIONS BIOLOGY (2021)
GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties
Robin Park et al.
BIOLOGY-BASEL (2021)
The PD-1 Interactome
Qi Wang et al.
ADVANCED BIOLOGY (2021)
Synergistic photothermal cancer immunotherapy by Cas9 ribonucleoprotein-based copper sulfide nanotherapeutic platform targeting PTPN2
Tao Yan et al.
BIOMATERIALS (2021)
Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor
Sean D. Allen et al.
BIOMATERIALS (2021)
AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
Ram Hari Pokhrel et al.
MOLECULAR CANCER (2021)
SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function
Marianne Strazza et al.
INFLAMMATION (2021)
Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer-A Clinicopathological Series
Marclesson Alves et al.
FRONTIERS IN ONCOLOGY (2021)
VRK2 inhibition synergizes with PD-1 blockade to improve T cell responses
Michael Peled et al.
IMMUNOLOGY LETTERS (2021)
Interleukin-2-inducible T-cell kinase (Itk) signaling regulates potent noncanonical regulatory T cells
Mahinbanu Mammadli et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection
Lynette Steele et al.
ISCIENCE (2021)
Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation
Hengqing Zhu et al.
ONCOGENE (2021)
Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK
Michael P. Gallagher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The Tec Kinase Itk Integrates Naive T Cell Migration and In Vivo Homeostasis
Flavian Thelen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Epstein-Barr Virus in Inborn Immunodeficiency-More Than Infection
Ciro Novaes Rosa Lino et al.
CANCERS (2021)
Bruton's Tyrosine Kinase and Its Isoforms in Cancer
Xianhui Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Genomic data from NSCLC tumors reveals correlation between SHP-2 activity and PD-L1 expression and suggests synergy in combining SHP-2 and PD-1/PD-L1 inhibitors
Keller J. Toral et al.
PLOS ONE (2021)
Influence of pentoxifylline on gene expression of PAG1/miR-1206/SNHG14 in ischemic heart disease
Ahlam Abd El-Aziz et al.
BIOCHEMISTRY AND BIOPHYSICS REPORTS (2021)
Upregulated PTPN2 induced by inflammatory response or oxidative stress stimulates the progression of thyroid cancer
Zhi Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity
Alexandra Schnell et al.
CELL RESEARCH (2020)
Small Molecule Inhibition of GSK-3 Specifically Inhibits the Transcription of Inhibitory Co-receptor LAG-3 for Enhanced Anti-tumor Immunity
Christopher E. Rudd et al.
CELL REPORTS (2020)
Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors
Fan Zhenzhen et al.
EMBO MOLECULAR MEDICINE (2020)
Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application
Xinrui Yuan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
The Scribble Complex PDZ Proteins in Immune Cell Polarities
Dante Barreda et al.
Journal of Immunology Research (2020)
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
Takahiro Domoto et al.
CELLS (2020)
The Role of GSK-3 in Cancer Immunotherapy: GSK-3 Inhibitors as a New Frontier in Cancer Treatment
Giuseppa Augello et al.
CELLS (2020)
The Role of GSK3β in T Lymphocytes in the Tumor Microenvironment
Anastasios Dimou et al.
FRONTIERS IN ONCOLOGY (2020)
PAG1 directs SRC-family kinase intracellular localization to mediate receptor tyrosine kinase-induced differentiation
Lauren Foltz et al.
MOLECULAR BIOLOGY OF THE CELL (2020)
PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T Cells
Markus Flosbach et al.
CELL REPORTS (2020)
Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions
Anna S. Tocheva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis
Kristina S. Lechner et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Revisiting the PD-1 pathway
Nikolaos Patsoukis et al.
SCIENCE ADVANCES (2020)
Coordinating Cytoskeleton and Molecular Traffic in T Cell Migration, Activation, and Effector Functions
Marta Mastrogiovanni et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Modulation of TCR Signaling by Tyrosine Phosphatases: From Autoimmunity to Immunotherapy
Patricia Castro-Sanchez et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cells
Alison Taylor et al.
BMC RESEARCH NOTES (2020)
Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation
Nikolaos Patsoukis et al.
COMMUNICATIONS BIOLOGY (2020)
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
Robert J. Walsh et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Inhibiting Bruton's Tyrosine Kinase in CLL and Other B-Cell Malignancies
Fabienne Lucas et al.
TARGETED ONCOLOGY (2019)
PTPN2 induced by inflammatory response and oxidative stress contributed to glioma progression
Liquan Wu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy
Javier Celis-Gutierrez et al.
CELL REPORTS (2019)
PTPN2 regulates the generation of exhausted CD8+ T cell subpopulations and restrains tumor immunity
Martin W. LaFleur et al.
NATURE IMMUNOLOGY (2019)
Development of Pyridine-based Inhibitors for the Human Vaccinia-related Kinases 1 and 2
Ricardo A. M. Serafim et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade
Mingxia Zhao et al.
ACTA PHARMACEUTICA SINICA B (2019)
Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
Kankana Bardhan et al.
SCIENTIFIC REPORTS (2019)
Glycogen synthase 3 (GSK-3) regulation of PD-1 expression and and its therapeutic implications
Janna Krueger et al.
SEMINARS IN IMMUNOLOGY (2019)
Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway
K. Kondo et al.
LEUKEMIA (2018)
Cyclin D-CDK4 kinase destabilizes PD-L1 via cullin 3-SPOP to control cancer immune surveillance
Jinfang Zhang et al.
NATURE (2018)
Affinity purification mass spectrometry analysis of PD-1 uncovers SAP as a new checkpoint inhibitor
Michael Peled et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells
Sadhak Sengupta et al.
CANCER LETTERS (2018)
PAG1 promotes the inherent radioresistance of laryngeal cancer cells via activation of STAT3
Li Shen et al.
EXPERIMENTAL CELL RESEARCH (2018)
Molecular and clinical characterization o PTPN2 expression from RNA-seq data of 996 brain gliomas
Peng-fei Wang et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Role of Bruton's tyrosine kinase in B cells and malignancies
Simar Pal Singh et al.
MOLECULAR CANCER (2018)
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
David A. Schaer et al.
CELL REPORTS (2018)
Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo
Giorgia Rota et al.
CELL REPORTS (2018)
PTPN2 Regulates Inflammasome Activation and Controls Onset of Intestinal Inflammation and Colon Cancer
Marianne R. Spalinger et al.
CELL REPORTS (2018)
Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
Na Luo et al.
ONCOIMMUNOLOGY (2018)
Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
Sabina Sandigursky et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Identification of Integrin β1 as a Novel PAG1-Interacting Protein Involved in the Inherent Radioresistance of Human Laryngeal Carcinoma
Xiaoxia Dong et al.
JOURNAL OF CANCER (2018)
PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation
Marianne R. Spalinger et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
PTPN2 regulates T cell lineage commitment and αβ versus γδ specification
Florian Wiede et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
CDK4/6 inhibition triggers anti-tumour immunity
Shom Goel et al.
NATURE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
Enfu Hui et al.
SCIENCE (2017)
The tyrosine phosphatase SHP-1 promotes T cell adhesion by activating the adaptor protein CrkII in the immunological synapse
Inbar Azoulay-Alfaguter et al.
SCIENCE SIGNALING (2017)
Transient CDK4/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion
Shenghui He et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The tyrosine phosphatase SHP-1 promotes T cell adhesion by activating the adaptor protein CrkII in the immunological synapse
Inbar Azoulay-Alfaguter et al.
SCIENCE SIGNALING (2017)
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8+ Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy
Alison Taylor et al.
FRONTIERS IN IMMUNOLOGY (2017)
GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity
Frank Cichocki et al.
CANCER RESEARCH (2017)
Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancer
Yunshu Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8+ Cytolytic T Cell Responses
Alison Taylor et al.
IMMUNITY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Repression of GSK3 restores NK cell cytotoxicity in AML patients
Reshmi Parameswaran et al.
NATURE COMMUNICATIONS (2016)
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
Chia-Wei Li et al.
NATURE COMMUNICATIONS (2016)
The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors
Dominique Davidson et al.
CELL REPORTS (2016)
The coreceptor programmed death 1 inhibits T-cell adhesion by regulating Rap1
Inbar Azoulay-Alfaguter et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Protein-tyrosine Phosphatase and Kinase Specificity in Regulation of SRC and Breast Tumor Kinase
Gaofeng Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Functions of Shp2 in cancer
Jie Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
CD28 Inhibits T Cell Adhesion by Recruiting CAPRI to the Plasma Membrane
Marianne Strazza et al.
JOURNAL OF IMMUNOLOGY (2015)
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Eleonore Beurel et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
Idit Sagiv-Barfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis
M. R. Spalinger et al.
MUCOSAL IMMUNOLOGY (2015)
Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
Thomas J. Raub et al.
DRUG METABOLISM AND DISPOSITION (2015)
Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations
Zhi-Hong Yu et al.
BIOCHEMISTRY (2014)
Interaction of membrane/lipid rafts with the cytoskeleton: Impact on signaling and function Membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling
Brian P. Head et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Programmed death-1 pathway in cancer and autoimmunity
Ariel Pedoeem et al.
CLINICAL IMMUNOLOGY (2014)
PTPN2 restrains CD8+ T cell responses after antigen cross-presentation for the maintenance of peripheral tolerance in mice
Florian Wiede et al.
JOURNAL OF AUTOIMMUNITY (2014)
Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells
Julio Gomez-Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
IL-2-Inducible T Cell Kinase Tunes T Regulatory Cell Development and Is Required for Suppressive Function
Weishan Huang et al.
JOURNAL OF IMMUNOLOGY (2014)
PAG - a multipurpose transmembrane adaptor protein
M. Hrdinka et al.
ONCOGENE (2014)
Roles of Raft-Anchored Adaptor Cbp/PAG1 in Spatial Regulation of c-Src Kinase
Takashi Saitou et al.
PLOS ONE (2014)
GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
Jing Zeng et al.
PLOS ONE (2014)
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
James N. Kochenderfer et al.
BLOOD (2013)
ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system
Sigrun Polier et al.
NATURE CHEMICAL BIOLOGY (2013)
Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression
D. M. Monsalve et al.
CELL DEATH & DISEASE (2013)
COX2 overexpression is a prognostic marker for Stage III breast cancer
Hee Sung Kim et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Human VRK2 (Vaccinia-related Kinase 2) Modulates Tumor Cell Invasion by Hyperactivation of NFAT1 and Expression of Cyclooxygenase-2
Marta Vazquez-Cedeira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia
Maria Kleppe et al.
BLOOD (2011)
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
Lars Anders et al.
CANCER CELL (2011)
Crystal Structure of Human Protein Tyrosine Phosphatase SHP-1 in the Open Conformation
Wei Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Differential Inhibitor Sensitivity between Human Kinases VRK1 and VRK2
Marta Vazquez-Cedeira et al.
PLOS ONE (2011)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma
Marta Puyol et al.
CANCER CELL (2010)
PDZ domains and their binding partners: structure, specificity, and modification
Ho-Jin Lee et al.
CELL COMMUNICATION AND SIGNALING (2010)
The space and time frames of T cell activation at the immunological synapse
Salvatore Valitutti et al.
FEBS LETTERS (2010)
VRK2 Inhibits Mitogen-Activated Protein Kinase Signaling and Inversely Correlates with ErbB2 in Human Breast Cancer
Isabel F. Fernandez et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Deletion of the protein tyrosine phosphatase gene PTPN2 in T-cell acute lymphoblastic leukemia
Maria Kleppe et al.
NATURE GENETICS (2010)
ITK Inhibitors in Inflammation and Immune-Mediated Disorders
Nisebita Sahu et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
SH2-Dependent Autophosphorylation within the Tec Family Kinase Itk
Raji E. Joseph et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
Shared and Distinct Genetic Variants in Type 1 Diabetes and Celiac Disease
Deborah J. Smyth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Modulation of Interleukin-1 Transcriptional Response by the Interaction between VRK2 and the JIP1 Scaffold Protein
Sandra Blanco et al.
PLOS ONE (2008)
Phosphoprotein associated with glycosphingolipid-enriched microdomains/Csk-binding protein: A protein that matters
Alexandr Svec
PATHOLOGY RESEARCH AND PRACTICE (2008)
The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines
Sandra Blanco et al.
FEBS JOURNAL (2006)
NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2
GK Yiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
COX-2 induces IL-11 production in human breast cancer cells
B Singh et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia
T Niihori et al.
JOURNAL OF HUMAN GENETICS (2005)
Transmembrane adaptor proteins in membrane microdomains:: important regulators of immunoreceptor signaling
V Horejsí
IMMUNOLOGY LETTERS (2004)
Characterization of three paralogous members of the mammalian vaccinia related kinase family
RJ Nichols et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3ζ signalosome and downstream signaling to PKCθ
KA Sheppard et al.
FEBS LETTERS (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Cyclin-dependent kinases regulate the antiproliferative function of Smads
I Matsuura et al.
NATURE (2004)
Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor
D Davidson et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells
LJ Appleman et al.
JOURNAL OF IMMUNOLOGY (2002)
Cutting edge: Negative regulation of immune synapse formation by anchoring lipid raft to cytoskeleton through Cbp-EBP50-ERM assembly
K Itoh et al.
JOURNAL OF IMMUNOLOGY (2002)
Interaction between two adapter proteins, PAG and EBP50:: a possible link between membrane rafts and actin cytoskeleton
N Brdicková et al.
FEBS LETTERS (2001)
The SHP-2 tyrosine phosphatase: Signaling mechanisms and biological functions
CK Qu
CELL RESEARCH (2000)
Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3
T Ohteki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase Csk and is involved in regulation of T cell activation
T Brdicka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts
Y Yashiro-Ohtani et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
